Equities

Anhui Huaheng Biotechnology Co Ltd

688639:SHH

Anhui Huaheng Biotechnology Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)38.86
  • Today's Change1.02 / 2.70%
  • Shares traded10.39m
  • 1 Year change-50.86%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Anhui Huaheng Biotechnology Co Ltd grew revenues 36.63% from 1.42bn to 1.94bn while net income improved 40.32% from 320.03m to 449.06m.
Gross margin30.29%
Net profit margin13.97%
Operating margin15.36%
Return on assets7.86%
Return on equity16.80%
Return on investment12.64%
More ▼

Cash flow in CNYView more

In 2023, Anhui Huaheng Biotechnology Co Ltd increased its cash reserves by 139.83%, or 205.52m. Cash Flow from Financing totalled 1.02bn or 52.86% of revenues. In addition the company generated 301.42m in cash from operations while cash used for investing totalled 1.13bn.
Cash flow per share--
Price/Cash flow per share--
Book value per share8.13
Tangible book value per share7.69
More ▼

Balance sheet in CNYView more

Anhui Huaheng Biotechnology Co Ltd has a Debt to Total Capital ratio of 52.41%, a higher figure than the previous year's 8.04%.
Current ratio0.6043
Quick ratio0.4316
Total debt/total equity1.10
Total debt/total capital0.5241
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 45.00% and 38.97%, respectively. The positive trend in dividend payments is noteworthy since only some companies in the Food Processing industry pay a dividend. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)47.27%
EPS growth(5 years)20.38
EPS (TTM) vs
TTM 1 year ago
-30.02
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.